Abstract 4634: Profile of Patients According to Chosen Therapeutic Strategy in the RecordAF Global Registry on Atrial Fibrillation Management
The ongoing RecordAF study is the first worldwide, prospective, observational survey of the real-life management of atrial fibrillation (AF) in recently diagnosed patients with a 1-year follow-up. We compared the characteristics of patients selected by physicians for rhythm control vs those selected for rate control at baseline. This abstract contains interim data on the first 2130 patients (35% of total planned enrolment). To evaluate patient characteristics associated with physicians’ choices of rhythm- or rate-control approaches to pharmacological therapy for AF. An international, observational, longitudinal cohort study of consecutive eligible patients ≥ 18 years old presenting with or treated for AF (≤ 1 year from diagnosis), whatever the purpose of their visit to randomly selected office- or hospital-based cardiologists. Of 2130 patients, 2099 were eligible for evaluation, coming from 21 countries in 12 regions (East US, West US, Germany/Austria, Russia, Belarus, France/UK, Other Eastern Europe, Northern Europe, Greece, Other Southern Europe, South America, Asia). The Table⇓ shows main characteristics that differed significantly between treatment strategies. Patients with ECG evidence of AF were more likely to be started on rate control than those not in AF. A history of heart failure, valvular heart disease, coronary artery disease, or myocardial infarction was associated with more use of rate control. Being in sinus rhythm or Caucasian was associated with more use of rhythm control. Based on the current enrolment, the presence of underlying heart disease and ongoing atrial fibrillation seem to lead to a preference for a rate-control strategy. Completion of the RecordAF trial will provide a large global registry of continuing treatment decisions and the success of current rhythm- or rate-control strategies for the management of AF.